Vibex QST - The True Blockbuster In The Antares Pharma Pipeline
My last article on Antares Pharma (NASDAQ:ATRS) focused on Otrexup approval and how it would transform Antares into a true proprietary product based biotech with growing earnings per share. The natural progression would be to show the investing public on why a successful Otrexup launch and commercialization will be able to fund the true blockbuster in the pipeline - Vibex QST. Vibex QST was briefly mentioned in my first article. This article outlines my investment thesis on why Vibex QST is the true gem in the pipeline and how it will be the dominant player in a $5B market in the next couple of years.
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|